ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
Orthofix Medical Inc

Orthofix Medical Inc (OFIX)

13.55
0.33
( 2.50% )
Updated: 12:45:48

Unlock more advanced trading tools

Join ADVFN today

Key stats and details

Current Price
13.55
Bid
13.54
Ask
13.56
Volume
108,955
13.13 Day's Range 13.84
9.575 52 Week Range 21.60
Market Cap
Previous Close
13.22
Open
13.13
Last Trade
2
@
13.56
Last Trade Time
12:48:49
Financial Volume
$ 1,466,324
VWAP
13.4581
Average Volume (3m)
358,030
Shares Outstanding
37,406,644
Dividend Yield
-
PE Ratio
-25.57
Earnings Per Share (EPS)
-0.53
Revenue
460.71M
Net Profit
-19.75M

About Orthofix Medical Inc

Orthofix Medical Inc. is a medical device company delivering orthopedic and spine solutions to healthcare providers. The company has two main segments: global spine, including bone growth and healing therapies, spinal implants, and regenerative tissue products; and global orthopedics, providing prod... Orthofix Medical Inc. is a medical device company delivering orthopedic and spine solutions to healthcare providers. The company has two main segments: global spine, including bone growth and healing therapies, spinal implants, and regenerative tissue products; and global orthopedics, providing products used in fracture repair, deformity correction, and bone reconstruction procedures. The majority of the company's sales come from the global spine segment in the United States. Orthofix distributes its products throughout North America, Europe, and several countries globally. The company provides solutions to hospitals, physicians, other healthcare providers, and patients. Show more

Sector
Surgical,med Instr,apparatus
Industry
Medical Instruments & Machines
Headquarters
Lewisville, Texas, USA
Founded
1980
Orthofix Medical Inc is listed in the Surgical,med Instr,apparatus sector of the NASDAQ with ticker OFIX. The last closing price for Orthofix Medical was $13.22. Over the last year, Orthofix Medical shares have traded in a share price range of $ 9.575 to $ 21.60.

Orthofix Medical currently has 37,406,644 shares outstanding. The market capitalization of Orthofix Medical is $504.99 million. Orthofix Medical has a price to earnings ratio (PE ratio) of -25.57.

OFIX Latest News

Orthofix Schedules First Quarter 2024 Earnings Release and Conference Call for May 7, 2024

Orthofix Medical Inc. (NASDAQ:OFIX), a leading global spine and orthopedics company, today announced that it will release its first quarter 2024 financial results on Tuesday, May 7, 2024 before...

Orthofix Names Andres Cedron as New Chief Legal Officer

Orthofix Medical Inc. (NASDAQ:OFIX), a leading global spine and orthopedics company, today announced that Andres Cedron has joined the company as Chief Legal Officer. This press release features...

Lucas Vitale Joins Orthofix as Chief People and Business Operations Officer

Orthofix Medical Inc. (NASDAQ:OFIX), a leading global spine and orthopedics company, today announced that Lucas Vitale has joined the company in the newly created role of Chief People and...

Orthofix Reports Fourth Quarter and Full Year 2023 Results

Recent Highlights Fourth quarter 2023 net sales of $200.4 million, an increase of 64% on a reported basis and 7% on a pro forma constant currency basis Bone Growth Therapies net sales growth of...

Orthofix Announces New President for Bone Growth Therapies Business

Orthofix Medical Inc. (NASDAQ:OFIX), a leading global spine and orthopedics company, today announced the appointment of Jason Shallenberger to President of the Bone Growth Therapies business, and...

Orthofix Schedules Fourth Quarter and Full Year 2023 Earnings Release and Conference Call for March 5, 2024

Orthofix Medical Inc. (NASDAQ:OFIX), a leading global spine and orthopedics company, today announced that it will release its fourth quarter and full year 2023 financial results on Tuesday, March...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10.171.2705530642813.3813.8412.8232062013.06639743CS
4-0.18-1.31099781513.7314.7612.8226265613.59583564CS
12-0.66-4.6446164672814.2114.7612.7535803013.7667269CS
262.2319.699646643111.3214.99.57561476112.64379723CS
52-6.38-32.012042147519.9321.69.57550624113.73873259CS
156-31.42-69.868801423244.9745.969.57527778417.92286102CS
260-41.07-75.192237275754.6257.859.57521282622.94997843CS

Market Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
CSSEChicken Soup for the Soul Entertainment Inc
$ 0.341
(123.90%)
162.52M
BOFBranchOut Food Inc
$ 2.18
(86.32%)
87.34M
AMSTAmesite Inc
$ 3.21
(60.50%)
64.11M
LICNLichen China Limited
$ 0.826
(47.50%)
13.06M
AIREreAlpha Tech Corporation
$ 0.87
(44.04%)
4.48M
NCINeo Concept International Group Holdings Ltd
$ 3.43
(-63.89%)
2.63M
ISUNiSun Inc
$ 0.0881
(-40.87%)
7.07M
GCTKGlucoTrack Inc
$ 0.4767
(-37.28%)
1.38M
EVOEvotec SE
$ 5.26
(-31.24%)
1.05M
ATXIAvenue Therapeutics Inc
$ 0.0942
(-29.70%)
8.45M
CSSEChicken Soup for the Soul Entertainment Inc
$ 0.341
(123.90%)
162.52M
TSLATesla Inc
$ 158.05
(9.24%)
124.94M
BOFBranchOut Food Inc
$ 2.18
(86.32%)
87.34M
SQQQProShares UltraPro Short QQQ
$ 11.965
(0.46%)
85.61M
AMSTAmesite Inc
$ 3.21
(60.50%)
64.11M

OFIX Discussion

View Posts
Monksdream Monksdream 2 months ago
OFIX 10Q due March 5
👍️0
Renee Renee 6 years ago
OFIX, Jeffrey Hammel, CPA, Brian McCollum, Kenneth Mack and Bryan McMillan SEC Litigation:

https://www.sec.gov/litigation/admin/2018/34-82933.pdf

👍️0
Renee Renee 12 years ago
OFIX: SEC Litigation:

http://www.sec.gov/litigation/litreleases/2012/lr22412.htm

U.S. SECURITIES AND EXCHANGE COMMISSION

Litigation Release No. 22412 /July 11, 2012

Securities and Exchange Commission v. Orthofix International N.V., United States District Court for the Eastern District of Texas, Case No. 4:12-CV-419 (filed July 10, 2012)

SEC CHARGES ORTHOFIX INTERNATIONAL WITH FCPA VIOLATIONS


The Securities and Exchange Commission today charged Texas-based medical device company Orthofix International N.V. with violating the Foreign Corrupt Practices Act (FCPA) when a subsidiary paid routine bribes referred to as “chocolates” to Mexican officials in order to obtain lucrative sales contracts with government hospitals.

The SEC alleges that Orthofix’s Mexican subsidiary Promeca S.A. de C.V. bribed officials at Mexico’s government-owned health care and social services institution Instituto Mexicano del Seguro Social (IMSS). The “chocolates” came in the form of cash, laptop computers, televisions, and appliances that were provided directly to Mexican government officials or indirectly through front companies that the officials owned. The bribery scheme lasted for several years and yielded nearly $5 million in illegal profits for the Orthofix subsidiary.

Orthofix agreed to pay $5.2 million to settle the SEC’s charges.

According to the SEC’s complaint filed in U.S. District Court for the Eastern District of Texas, the bribes began in 2003 and continued until 2010. Initially, Promeca falsely recorded the bribes as cash advances and falsified its invoices to support the expenditures. Later, when the bribes got much larger, Promeca falsely recorded them as promotional and training costs. Because of the bribery scheme, Promeca’s training and promotional expenses were significantly over budget. Orthofix did launch an inquiry into these expenses, but did very little to investigate or diminish the excessive spending. Later, upon discovery of the bribe payments through a Promeca executive, Orthofix immediately self-reported the matter to the SEC and implemented significant remedial measures. The company terminated the Promeca executives who orchestrated the bribery scheme.

The SEC’s proposed settlement is subject to court approval. Orthofix consented to a final judgment ordering it to pay $4,983,644 in disgorgement and more than $242,000 in prejudgment interest. The final judgment would permanently enjoined the company from violating Sections 13(b)(2)(A) and 13(b)(2)(B) of the Securities Exchange Act of 1934. Orthofix also agreed to certain undertakings, including monitoring its FCPA compliance program and reporting back to the SEC for a two-year period.

Orthofix also disclosed today in an 8-K filing that it has reached an agreement with the U.S. Department of Justice to pay a $2.22 million penalty in a related action.

The SEC’s investigation was conducted by Carol Shau and Alka N. Patel in the Los Angeles Regional Office. The SEC acknowledges and appreciates the assistance of the U.S. Department of Justice’s Criminal Division-Fraud Section and the Federal Bureau of Investigation.

SEC Complaint:

http://www.sec.gov/litigation/complaints/2012/comp22412.pdf
👍️0
Penny Roger$ Penny Roger$ 12 years ago
~ Monday! $OFIX ~ Earnings posted, pending or coming soon! In Charts and Links Below!

~ $OFIX ~ Earnings expected on Monday *
Want more like this? Search Keyword: MACMONEY >>> http://tinyurl.com/MACMONEY <<<
One or more of many earnings sites has alerted this security has or will be posting earnings on or around the day of this message.








http://stockcharts.com/h-sc/ui?s=OFIX&p=D&b=3&g=0&id=p88783918276&a=237480049




http://stockcharts.com/h-sc/ui?s=OFIX&p=W&b=3&g=0&id=p54550695994



~ Google Finance: http://www.google.com/finance?q=OFIX
~ Google Fin Options: hhttp://www.google.com/finance/option_chain?q=OFIX#
~ Yahoo! Finance ~ Stats: http://finance.yahoo.com/q/ks?s=OFIX+Key+Statistics
~ Yahoo! Finance ~ Profile: http://finance.yahoo.com/q/pr?s=OFIX
Finviz: http://finviz.com/quote.ashx?t=OFIX
~ BusyStock: http://busystock.com/i.php?s=OFIX&v=2


<<<<<< http://www.earningswhispers.com/stocks.asp?symbol=OFIX >>>>>>



http://investorshub.advfn.com/boards/post_prvt.aspx?user=251916

*If the earnings date is in error please ignore error. I do my best.
👍️0
Penny Roger$ Penny Roger$ 12 years ago
Orthofix International N.V. (Orthofix) is a diversified orthopedic products company. The Company offers a range of surgical and non-surgical products for the Spine, Orthopedics, Sports Medicine and Other Products market sectors. The Company’s products are designed to address the bone-and-joint health needs of patients of all ages. It designs, develops, manufactures, markets and distributes medical equipment used principally by musculoskeletal medical specialists for orthopedic applications. The Company operates in three segments: Spine, Orthopedics and Sports Medicine. Its primary research and development facilities are located in Fairfield, New Jersey; Verona, Italy; Lewisville, Texas; and Vista, California. During the year ended December 31, 2010, it closed certain facilities in the United States and Mexico and it subleased its facility in Boston, Massachusetts.

http://www.google.com/finance?q=OFIX
👍️0

Your Recent History

Delayed Upgrade Clock